Repeated cross-sectional analysis of hydroxychloroquine deimplementation in the AHA COVID-19 CVD Registry

There is little data describing trends in the use of hydroxychloroquine for COVID-19 following publication of randomized trials that failed to demonstrate a benefit of this therapy. We identified 13,957 patients admitted for active COVID-19 at 85 U.S. hospitals participating in a national registry b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradley, Steven M., Emmons-Bell, Sophia, Mutharasan, R. Kannan, Rodriguez, Fatima, Gupta, Divya, Roth, Gregory, Gluckman, Ty J., Shah, Rashmee U., Wang, Tracy Y., Khera, Rohan, Peterson, Pamela N., Das, Sandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302649/
https://www.ncbi.nlm.nih.gov/pubmed/34302004
http://dx.doi.org/10.1038/s41598-021-94203-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302649/
https://www.ncbi.nlm.nih.gov/pubmed/34302004
http://dx.doi.org/10.1038/s41598-021-94203-7

Ejemplares similares